Ads
related to: latanoprost ophthalmic solution- Diagnosing Resources
Review Resources For
Diagnosing Dry Eye In Patients.
- MOA Information
Learn How An Rx Is Designed To
Target Active & Inactive T Cells.
- Clinical Info For ECPs
See How An Rx Treatment Option
May Provide Lasting Relief.
- Review Clinical Data
Find Info About Efficacy & Clinical
Trials For An Rx Eye Drop.
- Diagnosing Resources
goodrx.com has been visited by 100K+ users in the past month
"A prescription drug card that actually does work" - BBB.org
ebay.com has been visited by 1M+ users in the past month
Search results
Results from the WOW.Com Content Network
Latanoprost, sold under the brand name Xalatan among others, is a medication used to treat increased pressure inside the eye (intraocular pressure). [5] This includes ocular hypertension and open-angle glaucoma. [5] Latanaprost is applied as eye drops to the eyes. [5] Onset of effects is usually within four hours, and they last for up to a day. [5]
Latanoprostene bunod, sold under the brand name Vyzulta, is an ophthalmic medication used for the reduction of intraocular pressure in people with open-angle glaucoma or ocular hypertension. [2] [3] It targets the trabecular meshwork directly. [3] It is a prostaglandin analog. [2]
Netarsudil/latanoprost, sold under the brand name Rocklatan among others, is a fixed-dose combination medication use to treat elevated intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension. [1] [2] It contains netarsudil mesylate and latanoprost. [1] [2] It is applied as eye drops to the eyes. [1] [2]
Latanoprost/timolol, sold under the brand name Xalacom, is a combination drug used for the treatment of glaucoma, consisting of latanoprost (increase uveoscleral outflow of aqueous humor [3]) and timolol (a beta blocker decreasing the production of aqueous fluid).
Netarsudil, sold under the brand name Rhopressa among others, is a medication for the treatment of glaucoma. [1] [2] [3] In the United States, in December 2017, the Food and Drug Administration (FDA) approved a 0.02% ophthalmic solution for the lowering of elevated intraocular pressure in people with open-angle glaucoma or ocular hypertension.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!